Calistoga Hires Public Company CFO
Seattle-based Calistoga Pharmaceuticals said today it has hired Andrew Guggenhime as its new chief financial officer. Guggenhime has an extensive network on Wall Street, after spending a decade as the chief financial officer of public biotech companies, including Facet Biotech (NASDAQ: FACT) and PDL Biopharma (NASDAQ: PDLI). Hiring a CFO with public company experience shouldn’t come as a big surprise. Calistoga CEO Carol Gallagher said back in June, when her company raised $40 million in venture capital to support development of a promising new drug for blood cancers, that she was laying the groundwork for a potential IPO.